A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
Researchers are looking for new ways to treat neovascular age-related macular degeneration (NVAMD). Available standard (usual) treatments for NVAMD, such as aflibercept, may not work for every person. Researchers want to learn if a trial medicine called tiespectus (also called MK-8748 or EYE201) can treat NVAMD. The goal of this trial is to learn if tiespectus works as well as aflibercept to treat NVAMD.
Epistemonikos ID: 7337c26d7abb224917a9d334c45e4ead9b70237c
First added on: Feb 28, 2026